Clinical Profile and Outcome of COVID-19 Cases Admitted at a Tertiary Health Facility In South-West Nigeria

T O Ojo1, T A Adetunji2, A A Amuda3

  • 1Department of Community Health, Obafemi Awolowo University and Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.

Insights

This study analyzed 65 Nigerian COVID-19 patients, finding male predominance and common symptoms like cough and breathlessness. Most patients recovered, but deaths occurred early in those with severe comorbidities.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Medicine

Background:

  • Coronavirus Disease 2019 (COVID-19) is a significant global health concern.
  • Nigeria experienced its third wave of COVID-19, necessitating increased hospitalizations.
  • Characterizing clinical profiles and outcomes is crucial for managing novel diseases like COVID-19.

Purpose of the Study:

  • To characterize the clinical profile of COVID-19 patients admitted to an isolation center in Nigeria.
  • To determine the outcomes of hospitalized COVID-19 patients.
  • To identify factors associated with COVID-19 patient outcomes in the Nigerian context.

Main Methods:

  • A case series design was employed.
  • Data were collected from 65 COVID-19 patients admitted between June 2020 and March 2021.
  • Demographic, clinical, treatment, and outcome data were analyzed.

Main Results:

  • The majority of patients (72.3%) were under 65 years old, with a male predominance (60.0%).
  • Common symptoms included cough (64.6%), breathlessness (63.1%), and fever (61.5%).
  • Hypertension (63.1%) and diabetes (27.7%) were the most frequent comorbidities; 66.2% received oxygen therapy, and 89.3% were discharged, with 9.2% mortality.

Conclusions:

  • Male patients were more prevalent in the isolation center.
  • All recorded COVID-19 mortalities occurred within five days of admission.
  • Prompt management of hypoxemia and comorbidities is recommended for favorable COVID-19 outcomes.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
488
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
61
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
56
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
79
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
408
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
368